ID   JC-49
AC   CVCL_A1EQ
SY   JFCR-Colorectal-49
DR   cancercelllines; CVCL_A1EQ
DR   Cosmic; 2811065
DR   Wikidata; Q102114301
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg302Ter (c.904C>T) (R284*); ClinVar=VCV000000798; Zygosity=Unspecified (PubMed=28179481).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1345Ter (c.4033G>T); ClinVar=VCV000449334; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
RX   PubMed=28179481; DOI=10.1158/1535-7163.MCT-16-0578;
RA   Tanaka N., Mashima T., Mizutani A., Sato A., Aoyama A., Gong B.,
RA   Yoshida H., Muramatsu Y., Nakata K., Matsuura M., Katayama R.,
RA   Nagayama S., Fujita N., Sugimoto Y., Seimiya H.;
RT   "APC mutations as a potential biomarker for sensitivity to tankyrase
RT   inhibitors in colorectal cancer.";
RL   Mol. Cancer Ther. 16:752-762(2017).
//